Versuchen GOLD - Frei
YOUR PERSONALIZED CANCER VACCINE
Scientific American
|December 2025
Vaccines based on mRNA can be tailored to target a cancer patient's unique tumor mutations. But crumbling support for cancer and mRNA vaccine research has endangered this promising therapy
AS SOON AS BARBARA BRIGHAM'S CANCEROUS PANCREATIC TUMOR was removed from her body in the fall of 2020, the buzz of a pager summoned a researcher to the pathology department in Memorial Sloan Kettering's main hospital in New York City, one floor below. Brigham, now 79, was recovering there until she felt well enough to go home to Shelter Island, near the eastern tip of Long Island. Her tumor and parts of her pancreas, meanwhile, were sent on an elaborate 24-hour course through the laboratory. Hospital staff assigned the organ sample a number and a unique bar code, then extracted a nickel-size piece of tissue to be frozen at -80 degrees Celsius. They soaked it in formalin to prevent degradation, then set it in a machine that gradually replaced the water in each cell with alcohol.
Next, lab staff pinned the pancreas to a foam block, took high-resolution images with a camera fixed overhead and used a scalpel to remove a series of sections of tumor tissue. These sections were embedded in hot paraffin and cut into slices a fraction of the thickness of a human hair, which were prepped, stained and mounted on glass slides to be photographed again. By the time a pathologist looked at Brigham's tumor under a microscope the next day, more than 50 people had helped steer it through the lab. Still, this work was all a prelude.
The real action came some two months later, when Brigham returned to the hospital to receive a vaccine tailored to the mutations that differentiated her tumor from the rest of her pancreas. Made of messenger RNA (mRNA) suspended in tiny fat particles, the vaccine was essentially a set of genetic instructions to help Brigham's immune system go after the mutant proteins unique to her tumor cells. It was, in other words, her very own shot.
Diese Geschichte stammt aus der December 2025-Ausgabe von Scientific American.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Scientific American
Scientific American
Probiotic Hope and Hype
Despite their popularity, supplements with billions of \"good\" microbes help only a few illnesses, research shows
3 mins
January 2026
Scientific American
Mondays Really Are More Stressful
The start of the workweek can be a biologically measurable stressor, with consequences for long-term health that can stretch into retirement
4 mins
January 2026
Scientific American
Tiny Display
An e-paper breakthrough brings extremely high-resolution color
2 mins
January 2026
Scientific American
Fine-Feathered Snack
A bat's tracker documents a dramatic midair hunt
2 mins
January 2026
Scientific American
OUR ROBOTIC PICTURE
Will mechanical helpers ever be commonplace at home, at work and beyond?
11 mins
January 2026
Scientific American
"Use Your Words" Can Be Good for Kids' Health
Writing or expressing feelings can help adults mentally and physically. Kids are no different
5 mins
January 2026
Scientific American
Distant Diplomacy
Unrelated species “talk” and understand one another to avoid threats
2 mins
January 2026
Scientific American
Behind the Nobel
A 2025 winner reflects on the mysterious T cells that won him the prize
5 mins
January 2026
Scientific American
A Suite of Killers
Heart ailments, kidney diseases and type 2 diabetes actually may be part of just one condition. It's called CKM syndrome
10 mins
January 2026
Scientific American
Static Launch
Tiny worms leap toward their fruit fly hosts with an electric “tractor beam”
3 mins
January 2026
Listen
Translate
Change font size
